- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Inadequately Treated Major Depressive Disorder (MDD)

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Inadequately Treated Major Depressive Disorder (MDD)
This is a National Virtual Event for all PsychU members.
In this presentation, the objectives are to:
- Describe the prevalence of depression in the US
- Highlight the burden of MDD
- Identify inadequately treated MDD and understand how it impacts patients
- Understand which patients are at risk for inadequately treated MDD
- Explain MDD treatment strategies

Christine Costa, Ph.D., DNP, RN, PMHNP-BC
Psychiatric nurse practitioner, Gateways Hospital and Mental Health Center; Associate Professor at California State University, Long Beach School of Nursing
More

Elika Hefazi, PharmD, BCPP
Medical Science Liaison
Speaker Christine Costa, Ph.D., DNP, RN, PMHNP-BC is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Elika Hefazi, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)